Effect of Whole-body Vibration Training in Patients With Renal Dialysis

NCT07049718 | Completed

• 1 other identifier: whole body vibration training
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

To show the effect of whole-body vibration in physical performance in patients with renal dialysis.

Conditions

Renal Dialysis

Keywords

Renal Dialysis; Whole-Body Vibration; Bone Mineral Density; Physical Performance

Outcome Measures

Primary Outcomes (2)

• bone mineral density

  Blood sample to take bone mineral density. (calcium \& phosphorus)

  3 months

• physical performance

  For participant's functional status will be evaluated by a series of physical performance tests

  3 months

Study Arms (2)

whole body vibration group

EXPERIMENTAL

Thirty male patients will receive whole body vibration twice / week for 12 weeks with duration from 30 to 60secound until reach 20 minutes and intensity begin from initially 5 HZ until reach 28 HZ gradually increase each 4 weeks in addition to medication (Red Blood Cell Stimulating Agents, Iron, Blood Pressure Medications, Phosphate Binders, Vitamins B and C, Calcitriol, Cinacalcet and Antibiotics).

Device: whole body vibration

control group

NO INTERVENTION

Thirty male patients will receive their own medication only (Red Blood Cell Stimulating Agents, Iron, Blood Pressure Medications, Phosphate Binders, Vitamins B and C, Calcitriol, Cinacalcet and Antibiotics).

Interventions

whole body vibration DEVICE

Whole-body vibration (WBV) is a training method that uses mechanical vibration and external resistance loading to stimulate the body, causing muscle vibration and increasing central nervous system adaptations (Rittweger, 2010).

whole body vibration group

Eligibility Criteria

• Age: 60 Years - 70 Years
• Sex: male
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• All patients that will be included in this study will meet the following criteria:
• Body mass index (BMI) from 25.0 to 29.9 kg/m2.
• Quitting smoking for more than 3 months.
• Their age will be ranged from 60-70 years old.
• Clinically and medically stable.
• Hemodialysis treatment over at least 6 months before enrollment.
• Patients with CKD (systolic blood pressure \< 140 mmHg diastolic blood pressure \< 90 mmHg and heart rate \< 80 bpm).
• The presence of kidney damage (i.e., albuminuria) or decreased kidney function (i.e. glomerular filtration rate (GFR) \< 60 ml/min per 1-73 m2) for 3 months or more irrespective of clinical diagnosis.

You may not qualify if:

• Patients will be excluded if they have:
• Patients with uncontrolled pulmonary disease.
• Patients with vascular severe complication as critical limb ischemia.
• Patients with unstable angina, uncontrolled cardiac arrhythmia, decompensated heart failure.
• Patients with severe musculoskeletal problems (e.g., severe knee osteoarthritis or post knee replacement surgeries).
• Any patients who missed more than two weeks of the program or want to terminate the program.

Sponsors & Collaborators

• Cairo University: lead

Study Sites (1)

Cairo university

Giza, Cairo University, Egypt

Location

Related Publications (20)

• Zierle-Ghosh A, Jan A. Physiology, Body Mass Index. 2023 Nov 5. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK535456/

  PMID: 30571077 BACKGROUND

• Zhanpeng F, Yan J, Fengrong Z, Sijie T. Estimation of peak oxygen pulse from body mass, resting heart rate, age, gender and systolic blood pressure in Chinese adults aged 20-39. Heliyon. 2023 Nov 4;9(11):e21912. doi: 10.1016/j.heliyon.2023.e21912. eCollection 2023 Nov.

  PMID: 38027988 BACKGROUND

• Bai Y, Huang L, Yin X, Sun Q, Zhang F. Effects of whole-body vibration exercise on physical function in patients with chronic kidney disease: a systematic review and meta-analysis. BMC Nephrol. 2024 Jan 3;25(1):2. doi: 10.1186/s12882-023-03436-3.

  PMID: 38172769 BACKGROUND

• van Heuvelen MJG, Rittweger J, Judex S, Sanudo B, Seixas A, Fuermaier ABM, Tucha O, Nyakas C, Marin PJ, Taiar R, Stark C, Schoenau E, Sa-Caputo DC, Bernardo-Filho M, van der Zee EA. Reporting Guidelines for Whole-Body Vibration Studies in Humans, Animals and Cell Cultures: A Consensus Statement from an International Group of Experts. Biology (Basel). 2021 Sep 27;10(10):965. doi: 10.3390/biology10100965.

  PMID: 34681065 BACKGROUND

• Chen TK, Knicely DH, Grams ME. Chronic Kidney Disease Diagnosis and Management: A Review. JAMA. 2019 Oct 1;322(13):1294-1304. doi: 10.1001/jama.2019.14745.

  PMID: 31573641 BACKGROUND

• Stenvinkel P, Carrero JJ, von Walden F, Ikizler TA, Nader GA. Muscle wasting in end-stage renal disease promulgates premature death: established, emerging and potential novel treatment strategies. Nephrol Dial Transplant. 2016 Jul;31(7):1070-7. doi: 10.1093/ndt/gfv122. Epub 2015 Apr 24.

  PMID: 25910496 BACKGROUND

• Sietsema KE, Amato A, Adler SG, Brass EP. Exercise capacity as a predictor of survival among ambulatory patients with end-stage renal disease. Kidney Int. 2004 Feb;65(2):719-24. doi: 10.1111/j.1523-1755.2004.00411.x.

  PMID: 14717947 BACKGROUND

• Seefried L, Genest F, Luksche N, Schneider M, Fazeli G, Brandl M, Bahner U, A Heidland A. Efficacy and safety of whole body vibration in maintenance hemodialysis patients - A pilot study. J Musculoskelet Neuronal Interact. 2017 Dec 1;17(4):268-274.

  PMID: 29199185 BACKGROUND

• Howden EJ, Fassett RG, Isbel NM, Coombes JS. Exercise training in chronic kidney disease patients. Sports Med. 2012 Jun 1;42(6):473-88. doi: 10.2165/11630800-000000000-00000.

  PMID: 22587820 BACKGROUND

• Rittweger J. Vibration as an exercise modality: how it may work, and what its potential might be. Eur J Appl Physiol. 2010 Mar;108(5):877-904. doi: 10.1007/s00421-009-1303-3. Epub 2009 Dec 12.

  PMID: 20012646 BACKGROUND

• Pavasini R, Guralnik J, Brown JC, di Bari M, Cesari M, Landi F, Vaes B, Legrand D, Verghese J, Wang C, Stenholm S, Ferrucci L, Lai JC, Bartes AA, Espaulella J, Ferrer M, Lim JY, Ensrud KE, Cawthon P, Turusheva A, Frolova E, Rolland Y, Lauwers V, Corsonello A, Kirk GD, Ferrari R, Volpato S, Campo G. Short Physical Performance Battery and all-cause mortality: systematic review and meta-analysis. BMC Med. 2016 Dec 22;14(1):215. doi: 10.1186/s12916-016-0763-7.

  PMID: 28003033 BACKGROUND

• Marinho PEM, Rocha LG, Araujo Filho JC, Araujo AXP, Andrade MDA, Taiar R, Paiva DN, Dornelas de Andrade A. Effects of whole-body vibration on muscle strength, quadriceps muscle thickness and functional capacity in kidney transplant recipients: A randomized controlled trial. J Bodyw Mov Ther. 2021 Apr;26:101-107. doi: 10.1016/j.jbmt.2020.10.005. Epub 2020 Oct 24.

  PMID: 33992228 BACKGROUND

• Munhoz EC, Hollanda R, Vargas JP, Silveira CW, Lemos AL, Hollanda RM, Ribeiro JP. Flattening of oxygen pulse during exercise may detect extensive myocardial ischemia. Med Sci Sports Exerc. 2007 Aug;39(8):1221-6. doi: 10.1249/mss.0b013e3180601136.

  PMID: 17762353 BACKGROUND

• Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT; Lancet Physical Activity Series Working Group. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet. 2012 Jul 21;380(9838):219-29. doi: 10.1016/S0140-6736(12)61031-9.

  PMID: 22818936 BACKGROUND

• Johnstone, L. M., Roshanravan, B., Rundell, S. D., Kestenbaum, B., Baker, S. F., Berry, D. L., & McGough, E. (2022). Instrumented and standard measures of physical performance in adults with chronic kidney disease. Journal of Acute Care Physical Therapy, 13(3), 110-118.

  BACKGROUND

• James Myhre et al.,( 2023). "Stages of Kidney Disease and Treatment", https://www.verywellhealth.com/stages-of-kidney-disease-8303978..

  BACKGROUND

• Isoyama N, Qureshi AR, Avesani CM, Lindholm B, Barany P, Heimburger O, Cederholm T, Stenvinkel P, Carrero JJ. Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. Clin J Am Soc Nephrol. 2014 Oct 7;9(10):1720-8. doi: 10.2215/CJN.10261013. Epub 2014 Jul 29.

  PMID: 25074839 BACKGROUND

• Housman, A. E., & Shropshire Lad, A. (2010). Incidence and prevalence. United States Renal Data System. 2010 Annual Data Report: atlas of chronic kidney disease and end-stage renal disease in the United States, 2.

  BACKGROUND

• Beddhu S, Baird BC, Zitterkoph J, Neilson J, Greene T. Physical activity and mortality in chronic kidney disease (NHANES III). Clin J Am Soc Nephrol. 2009 Dec;4(12):1901-6. doi: 10.2215/CJN.01970309. Epub 2009 Oct 9.

  PMID: 19820134 BACKGROUND

• Goodbred AJ, Langan RC. Chronic Kidney Disease: Prevention, Diagnosis, and Treatment. Am Fam Physician. 2023 Dec;108(6):554-561.

  PMID: 38215416 BACKGROUND

Study Officials

• Abdelrahman Abdelmoniem

  Cairo University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: June 17, 2025
• First Posted: July 3, 2025
• Study Start: February 15, 2025
• Primary Completion: May 21, 2025
• Study Completion: June 10, 2025
• Last Updated: July 3, 2025

Record last verified: 2025-06

Locations

EG (1)